| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |